Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2014
12/31/2014CN102143975B 特异性配体在msrv相关疾病中的治疗用途 Specific ligands associated diseases in msrv therapeutic use
12/31/2014CN102089326B 抗白细胞介素-6/白细胞介素-6受体的抗体及其使用方法 Anti-interleukin-6 / interleukin-6 receptor antibody and methods of use
12/31/2014CN101970499B 用于肿瘤治疗的单克隆抗体 Monoclonal antibodies for tumor therapy
12/30/2014US8921537 Anti-VEGF antibodies
12/30/2014US8921535 Infectious clones of torque teno virus
12/30/2014US8921529 Therapies for preventing or suppressing Clostridium difficile infection
12/30/2014US8921528 Bispecific fusion antibodies with enhanced serum half-life
12/30/2014US8921527 Antibody-containing solution formulations
12/30/2014US8921526 Mutated anti-TNFα antibodies and methods of their use
12/30/2014US8921525 Highly-functional mutant of humanized anti-EGFR antibody variable region
12/30/2014US8921524 Binding molecules
12/30/2014US8921523 Humanized anti-beta-amyloid antibodies
12/30/2014US8921522 Binding molecules
12/30/2014US8921520 Removal of serine proteases by treatment with finely divided silicon dioxide
12/30/2014US8921514 Anti-viral compounds
12/30/2014US8921281 Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants
12/30/2014US8921279 Display of binding agents
12/30/2014US8921106 Antibodies that bind the glutamate ligand binding region of NOTCH3
12/30/2014US8921097 Methods for expression and purification of immunotoxins
12/30/2014US8921071 Targeting poly-gamma-glutamic acid to treat Staphylococcus epidermidis and related infections
12/30/2014US8921058 Prostate tumor markers and methods of use thereof
12/30/2014US8920812 Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS
12/30/2014US8920811 Recombinant adenovirus useful for treating malignancy over-expressing proto-oncogene neu/erb B2
12/30/2014US8920809 Chimera comprising bacterial cytotoxin and methods of using the same
12/30/2014US8920806 Method of modulating inflammatory response by downregulation of activin
12/30/2014US8920805 Inhibition of tumor metastasis by anti-neuropilin 2 antibodies
12/30/2014US8920804 Methods and materials for the detection of dengue virus infection
12/30/2014US8920803 Immunotherapeutic method involving CD123 (IL-3Rα) antibodies and immunostimulating complex
12/30/2014US8920801 Methods and compositions for increasing arylsulfatase A activity in the CNS
12/30/2014US8920798 Myostatin binding agents, nucleic acids encoding the same, and methods of treatment
12/30/2014US8920797 Highly concentrated stabilized IgM solution
12/30/2014US8920776 Compositions and methods for the detection diagnosis and therapy of hematological malignancies
12/30/2014CA2780845C Fluoroimmunoassay method
12/30/2014CA2704119C Humanized anti-venezuelan equine encephalitis virus recombinant antibodies
12/30/2014CA2675847C Pegylated a.beta. fab
12/30/2014CA2542239C Multispecific deimmunized cd3-binders
12/30/2014CA2477234C Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
12/25/2014US20140380515 Transgenic transchromosomal rodents for making human antibodies
12/25/2014US20140378667 Transgenic Plants Modified for Reduced Cadmium Transport, Derivative Products, and Related Methods
12/25/2014US20140378666 Dual specificity antibodies and methods of making and using
12/25/2014US20140378664 Protein complex, bispecific antibody including the protein complex, and method of preparation thereof
12/25/2014US20140378663 Fc variants with reduced effector functions
12/25/2014US20140378653 Factor XII Inhibitors for the Treatment of Neurological Inflammatory Disorders
12/25/2014US20140378389 T cell receptors recognizing hla-a1- or hla-cw7-restricted mage
12/25/2014US20140377860 Anti-Bv8 Antibodies and Uses Thereof
12/25/2014US20140377858 Dual Variable Domain Immunoglobulin and Uses Thereof
12/25/2014US20140377806 Anti-cxcr3 antibodies and methods of use thereof
12/25/2014US20140377805 Dual Variable Domain Immunoglobulin and Uses Thereof
12/25/2014US20140377803 Enhancement of protein production yield mediated by a fast shuttling cdc42 gtpase
12/25/2014US20140377802 Novel P. Pastoris Pastoris Promoters, and the Use Thereof to Direct Expression of Proteins in Yeast, Preferably Using a Haploid Mating Strategy
12/25/2014US20140377781 Anti-Claudin 3 Monoclonal Antibody and Treatment and Diagnosis of Cancer Using the Same
12/25/2014US20140377740 Soluble and membrane-anchored forms of lassa virus subunit proteins
12/25/2014US20140377366 Biodegradable polymers for delivery of therapeutic agents
12/25/2014US20140377288 Compositions and methods related to dna damage repair
12/25/2014US20140377286 Detection and treatment of cd30+ cancers
12/25/2014US20140377284 Humanized anti-cd134 (ox40) antibodies and uses thereof
12/25/2014US20140377283 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (nait)
12/25/2014US20140377282 Anti-kdr antibodies and methods of use
12/25/2014US20140377281 Lectin-like oxidized ldl receptor 1 antibodies and methods of use
12/25/2014US20140377280 Non-sialylated anti-inflammatory polypeptides
12/25/2014US20140377279 Rsv-specific binding molecules and means for producing them
12/25/2014US20140377278 Compositions and Methods for Assessing and Treating Inflammatory Diseases and Disorders
12/25/2014US20140377277 Treatment of vasculoproliferative conditions with lrg1 anatgonists
12/25/2014US20140377276 Vascular endothelial cell growth factor antagonists
12/25/2014US20140377275 HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY FORMULATIONS
12/25/2014US20140377273 Anti-her3 antibodies and uses thereof
12/25/2014US20140377272 Anti-her3 antibodies and uses thereof
12/25/2014US20140377271 Naturally occurring autoantibodies against alpha-synuclein that inhibit the aggregation and cytotoxicity of alpha-synuclein
12/25/2014US20140377270 Optimized antibody variable regions
12/25/2014US20140377269 Multivalent antibody analogs, and methods of their preparation and use
12/25/2014US20140377268 Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer therapy
12/25/2014US20140377267 Antibodies to cross-linked amyloid beta oligomers
12/25/2014US20140377266 Methods and Compositions Involving NKG2D Inhibitors and Cancer
12/25/2014US20140377265 Anticoagulant antidotes
12/25/2014US20140377264 Polypeptide Formulation
12/25/2014US20140377262 Human monoclonal antibodies broadly protective against influenza b virus and methods of using the same
12/25/2014US20140377260 Protective vaccine based on staphylococcus aureus sa2074 protein
12/25/2014US20140377257 Combination therapy for b cell disorders
12/25/2014US20140377256 Optimized fc variants and methods for their generation
12/25/2014US20140377255 4-1bb binding molecules
12/25/2014US20140377254 Subtypes of humanized antibody against interleukin-6 receptor
12/25/2014US20140377253 Fc variants
12/25/2014US20140377221 Biomarkers and combination therapies using oncolytic virus and immunomodulation
12/25/2014US20140377181 Molecules with extended half-lives, compositions and uses thereof
12/25/2014US20140377172 Novel Antibody Recognizing a Small Subset of Human Hematopoietic Cells
12/25/2014US20140377168 Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin
12/24/2014CN104245933A 新的铁锌结合性调控因子以及通过其表达调节提高植物的耐缺铁性和促进可食用部分中的铁锌蓄积的技术 The new iron and zinc-binding regulatory factors and improve plant resistance by regulating the expression of iron deficiency and promote the edible portion of the iron and zinc accumulation technology
12/24/2014CN104245738A 针对人tweak和人il17的双特异性抗体及其用途 For people who tweak and il17 bispecific antibodies and their use
12/24/2014CN104245737A 抗adamts-5抗体,其衍生物和用途 Anti adamts-5 antibodies, their derivatives and use
12/24/2014CN104245735A Cx3cr1结合多肽 Cx3cr1 binding polypeptides
12/24/2014CN104245734A 靶向突变体α-螺旋束细胞因子 Targeting mutant α- helical bundle cytokine
12/24/2014CN104245733A 针对受体的双重可变结构域免疫球蛋白 For receptor dual variable domain immunoglobulin
12/24/2014CN104245732A 拮抗cd40l的抗体多肽 Cd40l antagonistic antibody polypeptides
12/24/2014CN104245731A 抗乙型流感病毒的广泛保护性人单克隆抗体及其使用方法 Anti-influenza B virus broad protective human monoclonal antibodies and methods of use
12/24/2014CN104245730A 源自血浆的免疫球蛋白的级分i-iv-1沉淀 Plasma-derived immunoglobulin fractions i-iv-1 precipitate
12/24/2014CN104245729A 序列对称性的修饰的IgG4双特异性抗体 Modified IgG4 sequence symmetry bispecific antibodies
12/24/2014CN104245728A 用于富集iga的方法 A method for enrichment iga
12/24/2014CN104244989A 含有新颖前药的分子组合物和其用途 Molecular composition containing the novel prodrugs and their uses
12/24/2014CN104244980A 经由FcγIIB促进抗原消除的抗原结合分子 Via FcγIIB promote antigen-binding molecule to eliminate the
12/24/2014CN104244979A 使用il-17拮抗剂治疗强直性脊柱炎的方法 Use il-17 antagonist treatment of ankylosing spondylitis method
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 1494